rxstatShortages › Ciclopirox

Ciclopirox shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 15, 2026

Ciclopirox is in a widespread shortage in Canada. 2 of 3 reported products are affected. Manufacturers have not committed to a recovery date.

An antifungal used on the skin and nails to treat fungal infections.

Products affected
2 / 3
In shortage since
Apr 7, 2017
Reports on file
8
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
When every manufacturer is affected, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
TARO-CICLOPIROX
8% · SOLUTION · TARO PHARMACEUTICALS INC
DIN 02353288 · since Aug 1, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
CICLOPIROX TOPICAL SOLUTION
8% · SOLUTION · STERIMAX INC
DIN 02410346 · since Apr 7, 2017, no end estimate · BUSINESS REASONS
Resolved
TARO-CICLOPIROX
8% · SOLUTION · TARO PHARMACEUTICALS INC
DIN 02353288 · ended Jul 12, 2024 · Disruption of the manufacture of the drug.
Resolved
TARO-CICLOPIROX
8% · SOLUTION · TARO PHARMACEUTICALS INC
DIN 02353288 · ended Jan 26, 2023 · Disruption of the manufacture of the drug.
Resolved
TARO-CICLOPIROX
8% · SOLUTION · TARO PHARMACEUTICALS INC
DIN 02353288 · ended Jun 1, 2020 · Disruption of the manufacture of the drug.
Resolved
TARO-CICLOPIROX
8% · SOLUTION · TARO PHARMACEUTICALS INC
DIN 02353288 · ended Aug 9, 2019 · Disruption of the manufacture of the drug.
Resolved
APO-CICLOPIROX
8% · SOLUTION · APOTEX INC
DIN 02298953 · ended May 22, 2019 · Disruption of the manufacture of the drug.
Resolved
TARO-CICLOPIROX
8% · SOLUTION · TARO PHARMACEUTICALS INC
DIN 02353288 · ended Jan 24, 2019 · Disruption of the manufacture of the drug.

What's happening

Ciclopirox is currently affected by 2 active shortage reports filed with Health Canada by TARO PHARMACEUTICALS INC, STERIMAX INC.

The reported causes are: disruption of the manufacture of the drug; business reasons. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Ciclopirox is classified under “ANTIFUNGALS FOR TOPICAL USE” (ATC D01AE).

Recent changes

Common questions

What is Ciclopirox used for?

An antifungal used on the skin and nails to treat fungal infections.

When will Ciclopirox be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Ciclopirox in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (antifungals for topical use)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.